Virtual tumor predicts response to liver cancer immunotherapy

Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine person developed a method to foretell which patients with a superior liver crab called hepatocellular carcinoma (HCC) would astir payment from operation attraction utilizing immunotherapy and a targeted therapy that blocks maturation signals connected which the tumor depends. The work, supported successful portion by the National Institutes of Health, was published online July 14 successful the Proceedings of the National Academy of Sciences.